Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 4Squamous Intraepithelial Lesions 4Uterine Cervical Dysplasia 2Anus Neoplasms 2Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Vaginal Neoplasms 1Recurrence 1Penile Neoplasms 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1HIV Seropositivity 1Anal Canal Carcinoma 1

Interventions

Colposcopy 18Imiquimod 14Conization 12Papillomavirus Vaccines 9Vaccines 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Papanicolaou Test 5Human Papillomavirus DNA Tests 5Blood Specimen Collection 5Watchful Waiting 4GX-188 vaccine 4Surveys and Questionnaires 3Cisplatin 3VGX-3100 2Transurethral Resection of Prostate 2Topotecan 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Indomethacin 2Immunohistochemistry 2Human Papillomavirus Recombinant Vaccine nonavalent 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × VGX-3100 × Gynecologic × Clear all
NCT03721978 2024-10-17

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Inovio Pharmaceuticals

Phase 3 Completed
203 enrolled 34 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡